HUBEI GUANGJI PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.09 CNY | -0.97% |
|
-12.24% | -36.30% |
| 2023 | Guangji Pharmaceutical Gets Nod to Produce Entecavir | MT |
| 2023 | Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Hubei Guangji Pharmaceutical Co., Ltd. is the Chinese leader of pharmaceutical ingredients production. The group's activity is organized around four product families:
- vitamins: riboflavin and beta carotene;
- food supplements;
- fine chemistry products;
- medicinal preparations.
Sector
Pharmaceuticals
Calendar
2024-04-25
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -36.30% | 251M | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
- Stock Market
- Equities
- 000952 Stock
- News Hubei Guangji Pharmaceutical Co., Ltd.
- Guangji Pharmaceutical Unit to Resume Production After Three-Month Stoppage
